The Professional Research Subject Problem In Clinical Trials

Clinical research patients are compensated for their participation in clinical trials. In some therapeutic areas and types of clinical trials, the compensation for enrolling in one or more clinical trials or at multiple research sites is enough to influence patients to join more than one contemporaneously and expose themselves to multiple investigational products or multiple …

Read more

Screen Shot 2019 06 15 at 9.25.12 AM

Case Study: Duplicate Subjects In Clinical Trials Cause Failure To Meet Endpoints

Your clinical trial is not meeting it’s endpoints and upon review, you detect there are duplicate subjects in your study. You and your teams spend several months trying to weed out these duplicate subjects. A new study must be performed. We hear this all the time. It occurs across most therapeutic indications and across the …

Read more

Key Research Sites In Germany Join Verified Clinical Trials Research Subject Registry To Prevent Duplicate Subjects & Over Enrollment To Improve Safety & Data Quality

Several premier research centers in Germany have led the initiative and joined the global Verified Clinical Trials (VCT) research subject database registry to prevent duplicate subjects and other important protocol violations in an effort to improve safety and data quality in their clinical trials. Key research sites in Germany join Verified Clinical Trials to prevent …

Read more

Screen Shot 2019 05 30 at 12.33.36 PM

Understanding Research Subjects Behaviors & Travel Habits: Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …

Read more

Screen Shot 2021 08 06 at 2.24.20 PM

Verified Clinical Trials Partners With The STARR Coalition To Promote Advocacy And Reduce Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) the leading global research subject database registry has teamed up with the STARR Coalition to create Project RockSTARR. The initiative allows sponsors to have research subjects that screen for a clinical trial donate a pre-allocated amount of money to local advocacy group of their choice. Advocacy and duplicate subject prevention in …

Read more

Screen Shot 2018 06 27 at 11.15.03 PM

No Specific Characteristics Of A Duplicate Subject And A Research Subject Database Is Required

Without a “tool” such as the Verified Clinical Trials (VCT) global research subjects database registry, detecting duplicate subjects and protocol violations based upon prior study history or prior study drug (IP) exposure is impossible. VCT proactively detects these issues at the time of screening before costly screening procedures occur. The protections continue the entire duration …

Read more

Screen Shot 2019 05 14 at 8.39.59 PM

Protect Your Clinical Trials Against Duplicate Subjects and Professional Research Subjects

If you protect your computers against malware and viruses, why not protect your clinical trials from duplicate subjects that cause data quality and safety issues as well as failed clinical trials?  Verified Clinical Trials (VCT) is the leading global research subject database to prevent duplicate subjects in clinical trials  also known as professional research subjects. …

Read more

Screen Shot 2018 04 19 at 3.41.36 PM

Duplicate Subjects In CNS Clinical Trials and Other Therapeutic Areas Prevented With Verified Clinical Trials Research Subject Database Registry

From phase 1 through phase 4 drug development, the issue of duplicate subjects in clinical trials exists.  Verified Clinical Trials (VCT). www.verifiedclinicaltrials.com is here to prevent these issues and promote safety and data quality.  Duplicate subjects in CNS clinical trials is especially needed, but VCT protects most therapeutic areas. Characteristics of duplicate subjects are not …

Read more

Screen Shot 2018 05 10 at 10.06.19 PM

CNS Clinical Trials Are Prone To Duplicate Subjects and Duplicate Enrollment

CNS clinical trials, especially psychiatry clinical trials are prone to having duplicate subjects in clinical trials.  In studies that rely upon subjective end points, there exists the ability to provide false information in an effort to gain entry in to the study.  Of course, these occurrences result in failed trials due to elevated placebo rates or issues with safety if the volunteer does in fact take the investigational product (IP) from multiple sites.

Use of the Verified Clinical Trials (VCT) global research subject registry has been quite effective at stopping these issues at the time of screening. The protections continue throughout the entire study.  The Verified Clinical Trials network is expansive and covers multiple countries worldwide.  Nearly every phase 1 unit across the United States and now in Europe and elsewhere.  VCT protects many therapeutic indications but is especially focused on duplicate subjects in CNS clinical trials and duplicate subjects in psychiatry clinical trials.

The data is rather impressive with as preventable protocol violations including duplicate or dual enrollment in clinical trials ranging higher than 10% in some instances.  The National Institute of Health (NIH) uses VCT exclusively.

Screenshot 2017 06 03 09.56.26 1

Duplicate Subjects In Clinical Trials Can Be Prevented With A Global Research Subject Registry

Duplicate subjects in clinical trials is unfortunately a common issue that affects all trials from most every indication and across all phases of clinical trials research.  These professional research subjects can be prevented by using Verified Clinical Trials (VCT) the global research subject registry.  Nearly all of the phase 1 units across the United States …

Read more